Cell Therapy Account Director - Launch & Growth (Remote)

Pierre Fabre; United States; A distancia; USD 170.000 - 250.000; Jornada completa

Descripción de la vacante

Pierre Fabre is building a new US division focusing on rare diseases and oncology, seeking a Cellular Therapy Director to lead launch efforts for Tab-cel. You will work with clinical and non-clinical experts to understand unmet needs and patient journeys, and to onboard transplant centers for allogeneic cell therapy.

In pre-approval, you will map accounts, build relationships, and develop disease awareness; post-approval, drive utilization and cross-functional collaboration to ensure access and

Formación

• Bachelor’s degree in a relevant field.
• 10+ years of experience within the biopharma industry.
• Deep expertise in cell or gene therapy service lines.
• Experience in a collaborative and complex matrix environment.
• Ability to convey complex treatment modalities to diverse stakeholders.
• Sales experience in ultra-rare disease, ideally CGT.

Responsabilidades

• Lead pre-approval disease awareness and relationships with clinical and non-clinical experts.
• Develop onboarding plans for launching allogeneic cell therapy.
• Post-approval, drive appropriate utilization and support patient access.
• Coordinate with medical affairs, market access, and cell therapy operations.
• Manage territory business plans with KPIs and tactics.
• Educate physicians on efficacy and safety to promote adoption.

Conocimientos

Account management

Cross-functional collaboration

Strategic planning

Scientific aptitude

Ultra-rare disease sales

Educación

Bachelor’s Degree

Descripción del empleo

Pierre Fabre is building a new US division focusing on rare diseases and oncology, seeking a Cellular Therapy Director to lead launch efforts for Tab-cel. You will work with clinical and non-clinical experts to understand unmet needs and patient journeys, and to onboard transplant centers for allogeneic cell therapy.

In pre-approval, you will map accounts, build relationships, and develop disease awareness; post-approval, drive utilization and cross-functional collaboration to ensure access and